The pervasiveness of Cyber in day-to-day business operations introduces serious legal, business and reputational risks to life sciences companies. Increasing regulations and customer, employee and shareholder expectations implore firms to identify, mitigate and transfer cyber risk. Join BIO Business Solution Partners, Aon & Chubb, on March 29 at 12:00 p.m. PT for a discussion on […]
Are you interested in learning how to leverage non-dilutive funding to advance your health and biomedical research? Through its Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding opportunities, the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health can help.
This ShareVault-sponsored web panel discussion with leaders in the microbiome research and development space will look at whether future advances in deciphering this paradigm can provide hope and revolutionize the healthcare industry and help innovate new ways to control disease and human growth, or whether the hype will unlock a Pandora’s Box of issues, which we understand very little about now.
In this live web panel, the panelists will discuss the role of non-immuno-oncology treatments for cancer in a world where immuno-oncology is playing a greater role. Biotech licensing and pharmaceutical business development consultant Linda Pullan will be joined by four panelists who are business development experts from global pharmaceutical companies, a leading academic cancer center, and a top business development consulting firm.
Oregon Bioscience Association Copyright 2023. All Rights Reserved.